PB2223: COST OF ILLNESS, EPIDEMIOLOGY AND HEALTHCARE RESOURCE UTILIZATION FOR SICKLE CELL DISEASE IN THE GULF “CESGU”

• D. Soliman,
• J. Altooq,
• S. Alkindi,
• H. Dewedar,
• A. Ibrahim,
• S. Elsawy

Affiliations

D. Soliman

1 Novartis Middle East, Dubai, United Arab Emirates

J. Altooq

2 Salmaniyah Medical Complex, Manama, Bahrain

S. Alkindi

3 Sultan Qaboos University, Muscat, Oman

H. Dewedar

4 Dubai health Authority

A. Ibrahim

5 Accsight, Dubai, United Arab Emirates

S. Elsawy

6 Accsight, Cairo, Egypt